PEStore

Buyout PE

WestBridge

WestBridge acquires controlling stakes in established, profitable businesses, from London, United Kingdom. It states a focus on healthcare & life sciences, business & professional services, consumer & retail and energy & utilities.

Disclosed holdings
Earliest stated investment
HeadquartersLondon, United Kingdom
Stated cheque sizeEBITDA ~£2-8m (profit)

Stated investment criteria

What WestBridge says it buys

Read from WestBridge’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.

Enterprise value it states$15m to $60m1
Transaction typesManagement buyout, Add-on2
OfficesLondon, Manchester1
People listed on its team page143

A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. WestBridge states that it takes majority or outright ownership. The team figure counts the people the firm shows on one team page, so it is a floor rather than a headcount: firms that split their team across tabs or load it in pages will read low. Nothing here is a commitment by WestBridge to consider any particular business, and nothing on this page is represented as being for sale.

Recorded transactions

Buying and selling

Deals in which WestBridge is named as buyer or seller in the transaction archive. 1 recorded exit, most recently in 2015. 4 recorded acquisitions.

CompanySideCounterpartyYearConsideration
AlpineBoughtCore Capital Partners LLP2022$29m
Smart Capital TechnologyBought2022$26m
Eque2BoughtLDC2020$72m
APEMBought2019$15m
Aero StanrewSoldTT Electronics2015$63m

Compiled from a transaction archive of 10,204 recorded deals. Most private transactions are never disclosed, so this is a sample of a firm’s activity rather than a complete record of it.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this WestBridge?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other buyout pe investors active in healthcare & life sciences.